Atorvastatin decreases apolipoprotein C-III in apolipoprotein B-containing lipoprotein and HDL in type 2 diabetes: a potential mechanism to lower plasma triglycerides.

G.M. Dallinga - Thie; I. Berk-Planken; A.H. Bootsma; H. Jansen

Atorvastatin decreases apolipoprotein C-III in apolipoprotein B-containing lipoprotein and HDL in type 2 diabetes: a potential mechanism to lower plasma triglycerides.

Translated title of the contribution: Atorvastatin decreases apolipoprotein C-III in apolipoprotein B-containing lipoprotein and HDL in type 2 diabetes: a potential mechanism to lower plasma triglycerides.

G.M. Dallinga - Thie
, I. Berk-Planken
, A.H. Bootsma
, H. Jansen

Internal Medicine

Research output: Contribution to journal › Article › Academic › peer-review

Translated title of the contribution	Atorvastatin decreases apolipoprotein C-III in apolipoprotein B-containing lipoprotein and HDL in type 2 diabetes: a potential mechanism to lower plasma triglycerides.
Original language	Undefined/Unknown
Pages (from-to)	1358-1364
Number of pages	7
Journal	Diabetes Care
Volume	27
Publication status	Published - 2004

Cite this

@article{b7addb4f2853477ea370783b26a2143f,

title = "Atorvastatin decreases apolipoprotein C-III in apolipoprotein B-containing lipoprotein and HDL in type 2 diabetes: a potential mechanism to lower plasma triglycerides.",

author = "\{Dallinga - Thie\}, G.M. and I. Berk-Planken and A.H. Bootsma and H. Jansen",

year = "2004",

language = "Undefined/Unknown",

volume = "27",

pages = "1358--1364",

journal = "Diabetes Care",

issn = "0149-5992",

publisher = "American Diabetes Association Inc.",

}

TY - JOUR

T1 - Atorvastatin decreases apolipoprotein C-III in apolipoprotein B-containing lipoprotein and HDL in type 2 diabetes: a potential mechanism to lower plasma triglycerides.

AU - Dallinga - Thie, G.M.

AU - Berk-Planken, I.

AU - Bootsma, A.H.

AU - Jansen, H.

PY - 2004

Y1 - 2004

M3 - Article

SN - 0149-5992

VL - 27

SP - 1358

EP - 1364

JO - Diabetes Care

JF - Diabetes Care

ER -